2013
DOI: 10.5731/pdajpst.2013.00898
|View full text |Cite
|
Sign up to set email alerts
|

Development of Matrix-Type Transdermal Delivery of Lornoxicam: In Vitro Evaluation and Pharmacodynamic and Pharmacokinetic Studies in Albino Rats

Abstract: The objective of the present work was to develop a matrix-type transdermal drug delivery system of lornoxicam with the addition of ethyl cellulose:polyvinylpyrrolidone and Eudragit RL 100:Eudragit RS 100 in different ratios with propylene glycol as plasticizer (5%) and tween 80 as permeation enhancer using the solvent evaporation technique. Lornoxicam is a non-steroidal anti-inflammatory drug that is used for the treatment of pain, inflammation, and arthritis. The prepared patches were evaluated for mechanical… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 22 publications
0
6
0
Order By: Relevance
“…Similar results were demonstrated by Baviskar et al where the matrix-type lornoxicam patches exhibited potent analgesic effect against thermal pain stimuli. [35]. Statistically, a significant difference was observed (P < 0.01) in the reaction time between the test and control group.…”
Section: In Vivo Analgesic and Anti-inflammatory Activitiesmentioning
confidence: 76%
See 1 more Smart Citation
“…Similar results were demonstrated by Baviskar et al where the matrix-type lornoxicam patches exhibited potent analgesic effect against thermal pain stimuli. [35]. Statistically, a significant difference was observed (P < 0.01) in the reaction time between the test and control group.…”
Section: In Vivo Analgesic and Anti-inflammatory Activitiesmentioning
confidence: 76%
“…Animals were divided into three groups (n = 6 for each group). Group I served as control, group II served as standard and received 4mg/kg LRX orally [35] and group III was treated with the optimized patch (4 cm 2 ). The test patch was applied topically on the posterior paw of each rat of the treated group and the response time was recorded after 0, 30, 60, 120 and 180 min after application.…”
Section: In Vivo Analgesic and Anti-inflammatory Activitiesmentioning
confidence: 99%
“…For the determination of the drug content of UHAE and UEO patches, samples were analyzed spectrophotometrically at 273 and 278 nm wavelength, respectively, after suitable dilution with phosphate buffer pH 7.4. Each experiment was performed in triplicate [ 28 ].…”
Section: Methodsmentioning
confidence: 99%
“…Each experiment was conducted in triplicate. Cumulative amounts of drug permeated were calculated in micrograms per square centimetre (μg/cm 2 ) and plotted against time [ 28 ].…”
Section: Methodsmentioning
confidence: 99%
“…1: Kp= Jss/C. 26,27 For this section, the protocols of animal handling procedures were performed in accordance with the CPCSEA guidelines.…”
Section: In Vitro Characterization Of Reservoir Gelmentioning
confidence: 99%